Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Deferasirox for Treating Patients Who Have Undergone Allogeneic Stem Cell Transplant and Have Iron Overload

This study has been terminated.
(Low enrollment)
Information provided by (Responsible Party):
City of Hope Medical Center Identifier:
First received: July 6, 2010
Last updated: July 16, 2012
Last verified: July 2012
No Study Results Posted on for this Study
  Study Status: This study has been terminated.
  Study Completion Date: August 2011
  Primary Completion Date: August 2011 (Final data collection date for primary outcome measure)